Rachel Ellingson - May 1, 2022 Form 4 Insider Report for ZIMMER BIOMET HOLDINGS, INC. (ZBH)

Role
SVP & Chief Strategy Officer
Signature
Matthew R. St. Louis, Attorney-in-Fact for Rachel Ellingson (power of attorney previously filed)
Stock symbol
ZBH
Transactions as of
May 1, 2022
Transactions value $
-$20,446
Form type
4
Date filed
5/3/2022, 04:41 PM
Previous filing
Mar 3, 2022
Next filing
May 10, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ZBH Common Stock Options Exercise $0 +531 +16.29% $0.00 3.79K May 1, 2022 Direct F1
transaction ZBH Common Stock Tax liability -$20.4K -167 -4.41% $122.43 3.62K May 1, 2022 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZBH Restricted Stock Units Options Exercise $0 -531 -100% $0.00* 0 May 1, 2022 Common Stock 531 Direct F3, F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 162 shares acquired under the Zimmer Biomet Holdings, Inc. Employee Stock Purchase Plan on June 30, 2021 and December 31, 2021.
F2 Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs").
F3 Each RSU represents a contingent right to receive one share of the Company's common stock.
F4 Amount reflects the adjustments that occurred as of March 1, 2022 in connection with the Company's spinoff of ZimVie Inc. In connection with the spinoff, each outstanding RSU was adjusted to preserve the intrinsic value of such award by multiplying it by an equity exchange ratio, rounded up to the nearest whole unit.
F5 The remaining 531 RSUs vested on May 1, 2022.